Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 7, Number 2—April 2001
THEME ISSUE
4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections

Introduction

Emergence of Vancomycin-Resistant Enterococci

Louis B. RiceComments to Author 
Author affiliation: VA Medical Center and Case Western Reserve University School of Medicine, Cleveland, Ohio, USA

Main Article

Table 1

Pre-treatment with antibiotics and vancomycin-resistant enterococci (VRE) colonization after gastric administration of 102 CFU vancomycin and ampicillin-resistant Enterococcus faecium C68 (46)

Approximate log10 CFU VRE/g stool

Day 3
Day 6
Day 9
Day 13
Day 16
Saline 2 2.5 3 2.5 2.5
Piperacillin-tazobactam 2 2 2 2 2
Ticarcillin-clavulanic acid >9 >9 8.2 6.8 6.8
Ceftriaxone >9 8.8 8.4 7.2 6

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO